Company profile · free preview
Novartis AG
NVS · NYSE · Healthcare · Updated 11/13/2026
Five-year financials
| Fiscal year |
|---|
| Revenue |
| Net income |
| Diluted EPS |
| Operating cash flow |
| Free cash flow |
| Cash |
| Total debt |
Financials are being prepared.
Want the story behind these numbers? Ask Osiris anything about Novartis AG's filings — free.
Create free accountNovartis AG return on capital (fiscal 2025)
ROIC
18.6%
Return on capital
19.0%
Return on equity
31.0%
Return on assets
13.1%
Gross margin
75.8%
Operating margin
31.1%
Net debt / EBITDA
0.96x
SEC filings
No filings stored yet.
Ask anything about Novartis AG's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching free